Rasi Seeds inks agreement with Israeli firm
date:Jun 27, 2012
Financial terms of the agreement were not disclosed. Under the collaboration, Rasi Seeds will be granted a license to candidate genes, identified and prioritised through Evogene's Athlete computational genomic technology and validated in model plants.

The Indian firm will integrate the licensed genes into its RD pipeline and evaluate them in rice field trials.

The agreement provides Rasi Seeds the right to commercialise hybrid rice incorporating these genes in India and in additional countri
1/2 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/02 15:37